Association of single nucleotide polymorphism in four genes and response to androgen deprivation therapy (ADT) in men with advanced hormone sensitive prostate cancer (aHSPC).

Authors

null

David Gill

University of Utah Huntsman Cancer Institute, Salt Lake City, UT

David Gill , Anitha Alex , James M. Farnham , Tyler Howard Buckley , Shiven B. Patel , Archana M. Agarwal , Craig Teerlink , Frederick S. Albright , Robert A Stephenson , Lisa A Cannon-Albright , Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 224)

DOI

10.1200/jco.2016.34.2_suppl.224

Abstract #

224

Poster Bd #

J17

Abstract Disclosures

Similar Posters

First Author: Lorelei A Mucci

Poster

2015 Genitourinary Cancers Symposium

Germ line predictors of response to androgen deprivation therapy in men with advanced prostate cancer.

Germ line predictors of response to androgen deprivation therapy in men with advanced prostate cancer.

First Author: Neeraj Agarwal

Poster

2013 Genitourinary Cancers Symposium

Effect of Gtx-758, an ERα agonist, on serum-free testosterone and serum PSA in men with advanced prostate cancer.

Effect of Gtx-758, an ERα agonist, on serum-free testosterone and serum PSA in men with advanced prostate cancer.

First Author: Evan Y. Yu

Poster

2012 Genitourinary Cancers Symposium

Testosterone suppression: Impact of testosterone level on disease progression in advanced prostate cancer.

Testosterone suppression: Impact of testosterone level on disease progression in advanced prostate cancer.

First Author: Shawn Dason